Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Molecular mechanisms underlying the development of neuroendocrine prostate cancer

Seminars in Cancer Biology(2022)10.1016/j.semcancer.2022.05.007Source: DataRank Database

Molecular mechanisms underlying the development of neuroendocrine prostate cancer is a research paper published in Seminars in Cancer Biology (2022). On theSindex it has a DataRank of 0. It has been cited 89 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

89 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 10.75)OA: closedTopics (31)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Busola R. Alabi ORCID,Qingqing Yin ORCID,Tanya Stoyanova ORCID,Shiqin Liu ORCID

Live enrichment

PubMed:35597438 OpenAlex:https://openalex.org/W4280504900

National Cancer Institute

Grant: R01CA244281

National Cancer Institute

Grant: R37CA240822

National Institutes of Health

FWCI

10.75

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

closedLicense: http://www.elsevier.com/open-access/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S1044579X22001183?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1044579X22001183?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.semcancer.2022.05.007

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35597438

Fields of Study

Prostate Cancer Treatment and ResearchRadiopharmaceutical Chemistry and ApplicationsPARP inhibition in cancer therapyMaleHumansProstatic NeoplasmsAndrogen AntagonistsCarcinoma, Neuroendocrine

MeSH Terms

Androgen AntagonistsHumansMaleProstatic NeoplasmsCarcinoma, Neuroendocrine

Keywords

Prostate cancerAndrogen deprivation therapyAndrogen receptorMedicineCancerProstateCancer researchAndrogenDiseaseOncologyNeuroendocrine differentiationInternal medicineBioinformaticsHormoneBiologyMolecular mechanismTherapeutic TargetsNeuroendocrine Prostate Cancer

Sustainable Development Goals

SDG 0: Good health and well-being